BERZERO, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 1.768
AS - Asia 1.669
NA - Nord America 1.525
SA - Sud America 551
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 37
OC - Oceania 2
Totale 5.670
Nazione #
US - Stati Uniti d'America 1.440
RU - Federazione Russa 1.014
CN - Cina 662
SG - Singapore 465
BR - Brasile 457
SE - Svezia 222
VN - Vietnam 192
HK - Hong Kong 189
IT - Italia 152
DE - Germania 97
FR - Francia 93
AR - Argentina 49
GB - Regno Unito 43
CA - Canada 40
BD - Bangladesh 33
MX - Messico 31
AT - Austria 25
ID - Indonesia 25
IN - India 25
FI - Finlandia 22
IE - Irlanda 17
NL - Olanda 15
JP - Giappone 14
ZA - Sudafrica 14
PL - Polonia 13
EC - Ecuador 12
ES - Italia 12
LT - Lituania 11
UA - Ucraina 11
CO - Colombia 10
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
IQ - Iraq 7
JM - Giamaica 7
MA - Marocco 7
TR - Turchia 7
PY - Paraguay 6
UY - Uruguay 6
A1 - Anonimo 5
CL - Cile 5
KE - Kenya 5
MY - Malesia 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
PH - Filippine 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DZ - Algeria 3
JO - Giordania 3
LB - Libano 3
NP - Nepal 3
VE - Venezuela 3
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GA - Gabon 2
IL - Israele 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
BZ - Belize 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SV - El Salvador 1
Totale 5.558
Città #
Singapore 228
Moscow 208
Hong Kong 189
New York 172
Shanghai 153
Ashburn 148
Dallas 148
San Jose 125
Hefei 77
Lauterbourg 72
Ho Chi Minh City 65
Lawrence 62
Princeton 62
Beijing 61
Hanoi 49
Los Angeles 48
São Paulo 46
Nuremberg 30
Secaucus 29
Orem 25
Milan 23
Munich 23
Santa Clara 22
Guangzhou 21
Newark 21
Dublin 17
Piscataway 17
Helsinki 16
Naples 16
North Bergen 16
Belo Horizonte 15
Curitiba 15
Brooklyn 13
Shenzhen 13
Stockholm 13
Warsaw 13
Montreal 12
Rome 12
Toronto 12
Clifton 11
Denver 11
Guarulhos 11
Rio de Janeiro 11
Tokyo 11
Vienna 11
Johannesburg 10
Mexico City 10
Porto Alegre 10
San Francisco 10
Falkenstein 9
Paris 9
Phoenix 9
Amsterdam 8
Chennai 8
Chicago 8
Houston 8
Poplar 8
Atlanta 7
Barnet 7
Boardman 7
Haiphong 7
Hangzhou 7
Jacksonville 7
Manchester 7
Washington 7
Wuxi 7
Jiaxing 6
London 6
Querétaro 6
Ankara 5
Brasília 5
Buenos Aires 5
Charlotte 5
Da Nang 5
Hải Dương 5
Joinville 5
Nairobi 5
Salvador 5
Seattle 5
Baghdad 4
Belém 4
Bengaluru 4
Berlin 4
Bolzano 4
Bắc Giang 4
Catanduva 4
Cuiabá 4
Foshan 4
Frankfurt am Main 4
Guayaquil 4
Hortolândia 4
Jackson 4
Kingston 4
Lappeenranta 4
Manassas 4
Miami 4
Montevideo 4
Quanzhou 4
Uberlândia 4
Vancouver 4
Totale 2.695
Nome #
Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature 250
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 134
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 123
CAR-T Cells for the Treatment of Central Nervous System Tumours: Known and Emerging Neurotoxicities 118
CSF-based liquid biopsy pointing to a diagnosis of diffuse glioma in a patient with supposed neurodegenerative disorder 111
Liquid biopsy in brain tumors: moving on, slowly 111
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 106
Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients 106
Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors 105
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis 105
Demyelinating polyradiculoneuritis in patients with multiple myeloma: the other side of bortezomib-induced neurotoxicity 100
CLIPPERS mimickers: relapsing brainstem encephalitis associated with anti-MOG antibodies 95
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies 93
Brain metastases from lung cancer: Is MET an actionable target? 93
Anti-Interleukin-6 and Janus Kinase Inhibitors for Severe Neurologic Toxicity of Checkpoint Inhibitors 92
Cranial nerve palsies in patients with hematological malignancies: a case series 91
Acute late-onset encephalopathy after radiotherapy: An unusual life-threatening complication 91
Current therapeutic approaches to diffuse grade II and III gliomas 91
Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy 91
Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disability 91
In vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas: The IDASPE Prospective Study 90
The coming of age of liquid biopsy in neuro-oncology 89
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies 89
Facing contrast-enhancing gliomas: Perfusion MRI in grade III and grade IV gliomas according to tumor area 88
Author response 88
CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient 86
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study 86
IDH-wildtype lower-grade diffuse gliomas: The importance of histological grade and molecular assessment for prognostic stratification 78
Stroke-like events after brain radiotherapy: a large series with long-term follow-up 72
Advanced neuroimaging studies: a patient-centered revolution 71
Glioblastomas 71
FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas 70
Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors 68
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies 68
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 67
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts 67
Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci 67
Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the Literature 67
Isolated seizures are a common early feature of paraneoplastic anti-GABA B receptor encephalitis 66
Neurological paraneoplastic syndromes: An update 66
Late-onset vascular complications of radiotherapy for primary brain tumors: a case–control and cross-sectional analysis 62
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies 62
Herpes simplex encephalitis in glioma patients: A challenging diagnosis 62
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 62
Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies 62
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review 61
Motor neuron disease of paraneoplastic origin: a rare but treatable condition 61
Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma 60
Targeting glioblastoma stem-cells: A recurrent challenge in neuro-oncology 60
MINCR: A long non-coding RNA shared between cancer and neurodegeneration 60
Hypersomnia in anti-glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study 58
Episodic Memory Impairments in Primary Brain Tumor Patients 58
Initial clinical presentation of young children with N-methyl-D-aspartate receptor encephalitis 58
Neuropathic pain, dysautonomia, and nerve hyperexcitability: Expanding the spectrum of LGI1 autoimmunity 57
Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults 56
Impact of multiple sclerosis risk loci in postinfectious neurological syndromes 56
Viral infections of the nervous system 56
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France 56
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors 56
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 55
Neurological syndromes associated with anti-gad antibodies 55
Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 54
Psychiatric symptoms in anti glutamic acid decarboxylase associated limbic encephalitis in adults: a systematic review 54
Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy 53
Leukoencephalopathy with transient splenial lesions related to 5-fluorouracil or capecitabine 53
The clinical use of IDH1 and IDH2 mutations in gliomas 53
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 52
Meningeal melanomatosis: a challenge for timely diagnosis 52
Sars‐Cov‐2 in a Patient with Acute Chorea: Innocent Bystander or Unexpected Actor? 52
Paraneoplastic cerebellar degeneration associated with Anti-ITPR1 antibodies 51
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma 51
The molecular landscape of glioma in patients with Neurofibromatosis 1 50
Neurological complications of chimeric antigen receptor T cells and immune-checkpoint inhibitors: ongoing challenges in daily practice 49
Gut microbiome alterations in anti-NMDA receptor encephalitis: caveats for result interpretation 47
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies 46
Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement 9
Totale 5.670
Categoria #
all - tutte 33.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.489


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202282 0 0 0 0 10 1 63 2 1 2 0 3
2022/2023401 139 87 19 4 4 56 19 20 29 1 5 18
2023/2024359 6 26 31 19 16 153 24 26 2 4 5 47
2024/20251.180 127 16 25 49 152 107 193 101 150 72 76 112
2025/20263.487 211 310 298 511 260 112 267 195 1.017 158 57 91
2026/2027159 153 6 0 0 0 0 0 0 0 0 0 0
Totale 5.670